Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Beyond Individual Patients: FDA Emphasizes Public Health Role In Certain Benefit-Risk Decisions
Oct 01 2021
•
By
Sarah Karlin-Smith
The kinds of data FDA looks at can influence its approval decisions • Source: Nielsen Hobbs
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership